AHZ 0.00% 6.0¢ admedus ltd

Ann: Annual Report to shareholders, page-2

  1. 5,999 Posts.
    lightbulb Created with Sketch. 320
    So $12m in kitty, revenues around $25m, total outgoings around $50m, loss around $25m.
    And Star Bright has two senior non exec directors on the BoD.

    So as it stand they will probably need to find $25m or so in funding, less any increase in revenues to keep everything on an even keel. Increase in costs partly due to increased R& D and foreign currency expenses for overseas staff.

    I guess for investors the two big things to hope for are increases in Adapt sales with the new distributors and TAVR research progress.

    IMO we will see Star Bright increase its stake in exchange for funding like last time.
    I guess they could be preparing to take over the company if the opportunity arises
    Last edited by whytee: 12/04/19
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.